Edgestream Partners’s Globus Medical GMED Stock Holding History

Edgestream Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,993	Closed	-$1.89M	–	1034
2026 Q1	$1.89M	Buy	+21,993	New	+$1.97M	0.06%	505
2025 Q4	–	Sell	-5,678	Closed	-$325K	–	1025
2025 Q3	$325K	Buy	+5,678	New	+$327K	0.01%	789
2024 Q4	–	Sell	-21,538	Closed	-$1.54M	–	942
2024 Q3	$1.54M	Buy	+21,538	New	+$1.52M	0.07%	471
2024 Q1	–	Sell	-27,945	Closed	-$1.49M	–	884
2023 Q4	$1.49M	Sell	27,945 -20,372	-42%	-$993K	0.11%	319
2023 Q3	$2.4M	Sell	48,317 -4,657	-9%	-$260K	0.19%	146
2023 Q2	$3.15M	Buy	+52,974	New	+$3.02M	0.29%	79

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Edgestream Partners's GMED Position: Q2 2026 in Review

Edgestream Partners sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 21,993 shares — an estimated $1.89M sold.

Edgestream Partners first reported a position in GMED in Q2 2023 and held it in 6 quarters. The position peaked at $3.15M in Q2 2023. 598 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Edgestream Partners reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Edgestream Partners sold 21,993 Globus Medical shares in Q2 2026, an estimated $1.89M.
Edgestream Partners first reported a position in Globus Medical in Q2 2023 and held it in 6 quarters.
Edgestream Partners's Globus Medical position peaked at $3.15M in Q2 2023.
598 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.